Organization
University of Groningen
9 abstracts
3 posters
Abstract
Identifying intra-abdominal desmoid type fibromatosis mimicking recurrence/metastasis of GISTs using FAPI PET/CT.Org: University Medical Center Groningen, University of Groningen, Department of Nuclear Medicine, Institute of Clinical Nuclear Medicine, Renji Hospital, The First Affiliated Hospital of Sun Yat-sen University, Department of Radiology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China,
Abstract
Updated results of the INTELLANCE 2/EORTC trial 1410 randomized phase II study on Depatux –M alone, Depatux-M in combination with temozolomide (TMZ) and either TMZ or lomustine (LOM) in recurrent EGFR amplified glioblastoma (NCT02343406).Org: Erasmus MC Cancer Center, Rotterdam, Netherlands Cancer Institute, Erasmus MC Cancer Institute, University Medical Center, Department of Hematology, Rotterdam, Netherlands, Fondazione IRCCS Istituto Neurologico Carlo Besta,
Abstract
Patients with EGFR mutant (m) MET-altered NSCLC receiving tepotinib with an EGFR tyrosine kinase inhibitor (TKI): A case series.Org: The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD), University Hospital of Cologne, China Medical University Hospital, Bhaktivedanta Hospital And Research Centre and School of Consciouness,
Abstract
Survival in patients with unresectable melanoma: To infinity and beyond?Org: University Medical Center of Utrecht, Amsterdam UMC, VU University Medical Center, Amsterdam, Netherlands, VU University Medical Center, Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital/Netherlands Cancer Institute,
Abstract
ABATACEPT TREATMENT OF PATIENTS WITH EARLY ACTIVE PRIMARY SJÖGREN’S SYNDROME – A RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED PHASEOrg: University Medical Center Groningen, University of Groningen, Rheumatology and Clinical Immunology Section, Oral and Maxillofacial Surgery, Gulhane Military Medical Academy, Ankara, Pathology and Medical Biology,
Abstract
AGE AND GENDER EFFECTS ON PROGRAMMED CELL DEATH-1 EXPRESSION IN HEALTHY DONORSOrg: University of Groningen, University Medical Center Groningen, Groningen, Netherlands,
Abstract
ASSESSING RECOVERY TIME AFTER COLD CHALLENGE AND THUMB INVOLVEMENT CAN HELP TO RULE OUT SYSTEMIC SCLEROSIS IN PATIENTS PRESENTING WITH RAYNAUD’S PHENOMENONOrg: University of Groningen, University Medical Center Groningen, Internal Medicine, Thomas Jefferson University, Philadelphia, United States, division Vascular Medicine, Rheumatology and Clinical Immunology, Biomedical Engineering, Vascular diseases, University Medical Center, Groningen, Netherlands,
Abstract
ASSESSMENT OF PULSE WAVE VELOCITY IN SYSTEMIC SCLEROSIS: POTENTIAL BENEFICIAL EFFECTS OF BOSENTAN ON FOREARM ARTERIAL STIFFNESS? AN EXPLORATORY STUDYOrg: University of Groningen, University Medical Center Groningen, Internal Medicine, Thomas Jefferson University, Philadelphia, United States, division Vascular Medicine, Groningen, Netherlands,
Abstract
ASSOCIATION OF PROTEINASE 3 GENE (PRTN3) Val119Ile POLYMORPHISM (SNP rs351111) WITH RISK OF RELAPSE AMONG HOMOZYGOUS PATIENTS WITH PR3 ANCA-ASSOCIATED VASCULITISOrg: Mayo Clinic, National Intitute of Health, Genentech Inc., University of Groningen, Cleveland Clinic Taussig Cancer Instititute,